Shielded (Extremely Vulnerable Patients) and shielding letters
Hadleigh Boxford Group Practice is aware that some highly vulnerable patients appear to have been excluded and not received letters sent out by NHS England week commencing 23rd March 2020. This is a national issue which is being addressed.
We are currently in the process of identifying anyone who should be shielded, and contacting all our shielded patients to ensure they understand what this means, how they should be shielding, and that they are made aware they can still access medical help if needed.
Please also note that we are not issuing letters to support applications for home delivered shopping.
For the latest information on who should be shielding, please click here:
- Solid organ transplant recipients.
- People with specific cancers:
- people with cancer who are undergoing active chemotherapy
- people with lung cancer who are undergoing radical radiotherapy
- people with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment
- people having immunotherapy or other continuing antibody treatments for cancer
- people having other targeted cancer treatments which can affect the immune system, such as protein kinase inhibitors or PARP inhibitors
- people who have had bone marrow or stem cell transplants in the last 6 months, or who are still taking immunosuppression drugs
- People with severe respiratory conditions including all cystic fibrosis, severe asthma and severe chronic obstructive pulmonary (COPD).
- People with rare diseases that significantly increase the risk of infections (such as SCID, homozygous sickle cell).
- People on immunosuppression therapies sufficient to significantly increase risk of infection.
- Women who are pregnant with significant heart disease, congenital or acquired.
Published: May 16, 2020